Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #16417 on Omni Health Inc (OMHE)
BubbaInSC
03/28/17 5:43 PM
#16418 RE: Miro Slovnik #16417
Revenue Our revenue from operations for the nine months ended January 31, 2017 was $3,270,793 compared to $117,853, an increase of $3,152,940, for the nine months ended January 31, 2016. This increase is primarily due to an increase in sales upon the acquisition of Malecon Pharmacy on June 22, 2017. Revenues consist primarily of results from the sales of prescription drugs, non-prescription drugs, and specialty products and related accessories.